BranchOut Food Inc. Announces $3.925M CEO-led Investment Including an Insider PIPE and Convertible note
July 24, 2024 07:00 ET
|
BranchOut Food Inc.
BranchOut Food Inc. Announces $3.925M CEO-led Investment Including an Insider PIPE and Convertible note
Roper Technologies announces second quarter financial results
July 24, 2024 06:55 ET
|
Roper Technologies, Inc.
SARASOTA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the second quarter ended June 30, 2024. The results in this press release are...
Media Advisory: Hut 8 Announces Conference Call to Discuss Second Quarter 2024 Results
July 24, 2024 06:30 ET
|
Hut 8 Corp.
MIAMI, July 24, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North...
Media Advisory: Hut 8 Announces Conference Call to Discuss Second Quarter 2024 Results
July 24, 2024 06:30 ET
|
Hut 8 Corp.
Miami, FL, July 24, 2024 (GLOBE NEWSWIRE) -- Media Advisory: Hut 8 Announces Conference Call to Discuss Second Quarter 2024 Results Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a...
Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus
July 24, 2024 06:00 ET
|
Nkarta, Inc.
SOUTH SAN FRANCISCO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced that...
Skye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” and Details Phase 2 Nimacimab Clinical Trial Design Including Obstructive Sleep Apnea Exploratory Endpoints
July 24, 2024 06:00 ET
|
Skye Bioscience, Inc.
SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic...
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
July 24, 2024 06:00 ET
|
Allarity Therapeutics, Inc.
Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments,...
Check Point Software Announces New CEO & Reports Strong 2024 Second Quarter Results
July 24, 2024 05:00 ET
|
Check Point Software Technologies INC
Nadav Zafrir, renowned Cyber Security leader, will assume CEO role December 2024 Gil Shwed, Founder & CEO, will transition to Executive Chairman REDWOOD CITY, Calif., July 24, 2024 (GLOBE...
Wah Fu Education Group Announces Its Entry into Educational AI and Informationization
July 24, 2024 04:00 ET
|
Wah Fu Education Group Limited
BEIJING, China, July 24, 2024 (GLOBE NEWSWIRE) -- Wah Fu Education Group Limited (“Wah Fu” or the “Company”) (NASDAQ: WAFU), a provider of online education and exam preparation services, as well as...
PDF Solutions חתמה על הסכם עם ADMATI Agencies שתשמש כנציגת המכירות שלה
July 24, 2024 03:36 ET
|
PDF Solutions, Inc.
סנטה קלרה, קליפורניה, July 24, 2024 (GLOBE NEWSWIRE) -- (PDFS:נאסד"ק) PDF Solutions, Inc., ספקית מובילה של פתרונות נתונים מקיפים לאקו סיסטם של שוק המוליכים למחצה והאלקטרוניקה, הודיעה...